Cargando…
Adaptive Subsets Limit the Anti-Tumoral NK-Cell Activity in Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is a global health burden with increasing incidence, poor prognosis and limited therapeutic options. Natural killer (NK) cells exhibit potent anti-tumoral activity and therefore represent potential targets for immunotherapeutic approaches in HCC treatment. However, the...
Autores principales: | Rennert, Charlotte, Tauber, Catrin, Fehrenbach, Pia, Heim, Kathrin, Bettinger, Dominik, Sogukpinar, Özlem, Schuch, Anita, Zecher, Britta Franziska, Bengsch, Bertram, Lang, Sven A., Bronsert, Peter, Björkström, Niklas K., Fichtner-Feigl, Stefan, Schultheiss, Michael, Thimme, Robert, Hofmann, Maike |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8227986/ https://www.ncbi.nlm.nih.gov/pubmed/34199483 http://dx.doi.org/10.3390/cells10061369 |
Ejemplares similares
-
CD8(+) T Cell Responses during HCV Infection and HCC
por: Hofmann, Maike, et al.
Publicado: (2021) -
Hepatitis B vaccine and NK cells: a new player in memory
por: Hofmann, Maike, et al.
Publicado: (2021) -
Priming persistence of HCV
por: Schuch, Anita, et al.
Publicado: (2015) -
Follicular T Helper Cell Signatures in Primary Biliary Cholangitis and Primary Sclerosing Cholangitis
por: Adam, Leonie, et al.
Publicado: (2018) -
Nonsurgical Therapeutic Options in Portal Vein Thrombosis
por: Schultheiß, Michael, et al.
Publicado: (2014)